Inspire Medical Systems, Inc. (NYSE:INSP) Position Lifted by Nisa Investment Advisors LLC

Nisa Investment Advisors LLC raised its stake in Inspire Medical Systems, Inc. (NYSE:INSP) by 37.3% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 368 shares of the company’s stock after purchasing an additional 100 shares during the period. Nisa Investment Advisors LLC’s holdings in Inspire Medical Systems were worth $68,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of INSP. Wealth Enhancement Advisory Services LLC boosted its holdings in Inspire Medical Systems by 1.0% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 7,879 shares of the company’s stock worth $1,461,000 after purchasing an additional 79 shares during the period. Signaturefd LLC boosted its holdings in shares of Inspire Medical Systems by 45.9% in the 3rd quarter. Signaturefd LLC now owns 270 shares of the company’s stock valued at $57,000 after buying an additional 85 shares during the period. The Manufacturers Life Insurance Company grew its position in shares of Inspire Medical Systems by 0.4% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 21,193 shares of the company’s stock valued at $2,836,000 after buying an additional 92 shares during the last quarter. Quarry LP raised its stake in Inspire Medical Systems by 30.9% during the third quarter. Quarry LP now owns 449 shares of the company’s stock worth $95,000 after acquiring an additional 106 shares during the period. Finally, KBC Group NV lifted its holdings in Inspire Medical Systems by 16.9% in the third quarter. KBC Group NV now owns 870 shares of the company’s stock worth $184,000 after acquiring an additional 126 shares during the last quarter. Institutional investors and hedge funds own 94.91% of the company’s stock.

Analyst Upgrades and Downgrades

INSP has been the topic of a number of research reports. Robert W. Baird increased their price target on Inspire Medical Systems from $240.00 to $252.00 and gave the stock an “outperform” rating in a research report on Tuesday, November 5th. Stifel Nicolaus dropped their target price on Inspire Medical Systems from $200.00 to $190.00 and set a “hold” rating on the stock in a research report on Tuesday, January 21st. KeyCorp reiterated an “overweight” rating and issued a $234.00 target price (down from $236.00) on shares of Inspire Medical Systems in a research note on Friday, January 24th. Piper Sandler restated an “overweight” rating and set a $260.00 price target (up previously from $255.00) on shares of Inspire Medical Systems in a research report on Tuesday, November 5th. Finally, Bank of America upgraded shares of Inspire Medical Systems from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $220.00 to $255.00 in a research report on Wednesday, November 20th. Three equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. Based on data from MarketBeat, Inspire Medical Systems has an average rating of “Moderate Buy” and a consensus target price of $231.45.

Inspire Medical Systems Trading Up 2.3 %

Shares of NYSE:INSP opened at $194.38 on Friday. The company has a 50 day moving average of $189.95 and a 200-day moving average of $187.94. The firm has a market cap of $5.83 billion, a P/E ratio of 181.67 and a beta of 1.32. Inspire Medical Systems, Inc. has a twelve month low of $123.00 and a twelve month high of $257.40.

Inspire Medical Systems (NYSE:INSP) last released its earnings results on Monday, November 4th. The company reported $0.60 earnings per share for the quarter, topping analysts’ consensus estimates of $0.06 by $0.54. Inspire Medical Systems had a return on equity of 5.30% and a net margin of 4.37%. The firm had revenue of $203.20 million during the quarter, compared to the consensus estimate of $197.59 million. During the same period in the prior year, the firm posted ($0.29) earnings per share. The firm’s revenue for the quarter was up 32.6% compared to the same quarter last year. Equities research analysts forecast that Inspire Medical Systems, Inc. will post 1.35 EPS for the current year.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.